AI assistant
Sending…
BiomX Inc. — Director's Dealing 2020
Mar 27, 2020
35099_dirs_2020-03-27_0fc7ef75-b284-4a1f-bd6a-2cbad9e8b390.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2020-03-25
Reporting Person: GROSSMAN JONAS (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-25 | Common Stock Options - Right to Buy | $6.21 | A | 16000 | Acquired | 2030-03-25 | Common Stock (16000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0001 | 6500 | Direct |
| Common Stock, par value $0.0001 | 1707500 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $11.5 | 2024-10-28 | Common Stock (50129) | 50129 | Direct |
Footnotes
F1: Consists of shares of common stock owned by Chardan Investments, LLC, for which Mr. Grossman is the managing member. Mr. Grossman disclaims beneficial ownership of the shares except to the extent of his pecuniary interest in the shares.
F2: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.
More from BiomX Inc.
Proxy Solicitation & Information Statement
2026
Jun 8
Transaction in Own Shares
2026
Jun 5
Board/Management Information
2026
May 28
Interim / Quarterly Report
2026
May 20
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 10
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 10
Regulatory Filings
2026
Apr 10